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Objective: Airway replacement after long-segment tracheal resection for benign and malignant disease remains
a challenging problem because of the lack of a substitute conduit. Ideally, an airway substitute should be well
vascularized, rigid, and autologous to avoid infections, airway stenosis, and the need for immunosuppression.
We report the development of an autologous tracheal substitute for long-segment tracheal resection that satisfies
these criteria and demonstrates excellent short-term functional results in a large-animal study.
Methods: Twelve adult pigs underwent long-segment (6 cm, 60% of total length) tracheal resection. Autologous
costal cartilage strips measuring 6 cm3 2 mm were harvested from the chest wall and inserted at regular 0.5-cm
intervals between dermal layers of a cervical skin flap. The neotrachea was then scaffolded by rotating the com-
posite cartilage skin flap around a silicone stent measuring 6 cm in length and 1.4 cm in diameter. The neotrachea
replaced the long segment of tracheal resection, and the donor flap site was closed with a double-Z plasty. Animals
were killed at 1 week (group I, n¼ 4), 2 weeks (group II, n ¼ 4), and 5 weeks (group III, n¼ 4). In group III the
stent was removed 1 week before death. Viability of the neotrachea was monitored by means of daily flexible
bronchoscopy and histologic examination at autopsy. Long-term morbidity and mortality were determined by
monitoring weight gain, respiratory distress, and survival.
Results: There was no mortality during the study period. Weight gain was appropriate in all animals. Daily bron-
choscopy and postmortem histologic evaluation confirmed excellent viability of the neotrachea. There was no
evidence of suture-line dehiscence. Five animals had distal granulomas that were removed by using rigid bron-
choscopy. In group III 1 animal had tracheomalacia, which was successfully managed by means of insertion of
a silicon stent.
Conclusion:Airway reconstruction with autologous cervical skin flaps scaffolded with costal cartilages is a novel
approach to replace long segments of resected trachea. This preliminary study demonstrates excellent respiratory
function and survival in large animals undergoing resection of more than 50% of their native trachea. Use of cer-
vical skin flaps buttressed with costal cartilage is a promising solution for long-segment tracheal replacement.Tracheal surgery has evolved rapidly since the first reports
by Hermes Grillo in 1965.1,2 Tracheal resection is performed
for a host of airway diseases, such as postintubation stenosis,
local invasion by adjacent cancers (ie, thyroid cancer), or
primary tracheal malignancies.3 Currently, resection of
long segments of trachea is managed by using primary rean-
astomosis. This approach has limited the length of trachea
that can be safely removed. Most reports suggest 4 to
5 cm of trachea or approximately 8 tracheal rings can be re-
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that can be performed without additional maneuvers. Pulmo-
nary hilar release, suprahyoid release, and cervical neck flex-
ion have been used to decrease anastomotic tension. Despite
these additional maneuvers, longer segments of the trachea
cannot be removed without compromising the safety of the
patient. This often results in positive margins and inadequate
resections in patients with malignant invasion of the trachea
and primary tracheal cancers. Currently, the only available
alternative is mediastinal tracheostomy, a procedure that car-
ries a high morbidity and mortality.
After resection of long tracheal segments, a replacement is
needed that would alleviate the problems of primary repair.
The ideal conduit should be a well-vascularized and autolo-
gous tissue that does not incite an immune response. This
conduit should also have longitudinal flexibility and trans-
verse rigidity that mimics that of cartilage rings. Further-
more, it should retain the ability to clear secretions. The
technique of construction for the neotracheamust be straight-
forward and the results predictably successful to overcome
the issue of long-segment tracheal reconstruction. Conduitsery c July 2009
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rigidity and often collapse during the expiratory phase. Fur-
thermore, they retain the ability to clear secretions. Two ap-
proaches are being used by several investigators to develop
a substitute for the long segment of tracheal resection: re-
placement with prosthetic material and biologic grafts.
Prosthetic conduits have had several limitations. The use of
artificialmaterial has beenprone to infection, granulation, and
airway obstruction.6 Conduits that use metallic or silicon
stents have problems with inflammatory granulation tissue
that ultimately occludes the airway.7-9 In repeated studies
prosthetic replacement of the trachea results in infection,
granulation, obstruction, and migration. These artificial con-
duits do not incorporate native tissue,which ultimately causes
them to fail. An alternative approach using biologic grafts is
being tested by several groups. Yu and associates10 recently
presented their results with a composite radial forearm free
flap and prosthesis to replace a long segment of the trachea.
Based on these observations, we have developed the first
reproducible autologous tracheal substitute that consistently
provides excellent results. We have constructed a conduit
using a rotational cervical skin flap that has cartilage rings
inserted between the dermal layers and transiently rotated
around a stent. We have demonstrated the feasibility and re-
sults of this approach in a large-animal model.
MATERIALS AND METHODS
Animal Model
Twelve immunocompetent male large white pigs (17–25 kg) were pur-
chased from Etablissements Cegav (St Marc d’Egrenne, France). They
were handled in compliance with the ‘‘Guide for the care and use of labo-
ratory animals’’ (http://www.nap.edu/catalog/5140.html). The animals re-
ceived care in accordance with French regulations and institutional ethics
committee guidelines for animal research. Large white pigs have a typical
tracheal length of 10 cm from the cricoid cartilage to the right upper lobe
bronchial segment. Their tracheobronchial anatomy resembles human anat-
omy, except the right upper lobe bronchial segment branches 2 cm above the
carina.
Preparation for Animal Operations
Anesthesia was induced with intramuscular ketamine (100 mg/kg) and
maintained with intravenous pentobarbital (10 mg/kg bolus, followed by
a continuous infusion of 0.1 mg. kg1. min1). The animals were par-
alyzed with pancuronium (0.3 mg/kg). After endotracheal intubation, inter-The Journal of Thoracic andmittent positive-pressure ventilation was provided (MMS 107 ventilator;
MMS, Pau, France) at a tidal volume of 15 mL/kg, with a respiratory rate
of 18 cycles/min and a fraction of inspired oxygen of 0.5. Body temperature
was kept constant at 37C. Peripheral vascular access was accomplished by
placing a 20-gauge angiocatheter into an ear vein. The adequacy of ventila-
tion and oxygenation was assessed by means of pulse oximetry. Continuous
monitoring of cardiac electrical activity was also performed.
Costal Cartilage Harvest
The animal was placed in a supine position. An incision was made over
the most caudal palpable rib. Animals have 13 ribs, each with a costal car-
tilage along the anterior one fourth of the rib. We exposed the last 3 ribs on
the left chest wall and excised the costal cartilage without opening the pleura
or violating the internal thoracic artery. These strips of cartilage were di-
vided lengthwise with a no. 15 scalpel. These fragments were cut out to
be approximately 2 mm thick 3 5 cm long 3 5 mm wide. The end of
each cartilage fragment was fashioned into a triangular shape (Figure 1).
Autologous Tracheal Reconstruction
Once the lateral chest incisionwas closed, the pigwasmarkedwith a rect-
angle 6 cm along the length of the trachea and 5 cm wide centered on the
trachea. Three sides of this box were incised at full thickness (Figure 2).
This skin flap was lifted up and moistened with a sponge. The trachea
was now readily exposed underneath. The thyroid was retracted to the right
side. With full neck extension, the trachea could be visualized from the cri-
coid cartilage to 3 cm above the carina. The carina could be palpated by
means of pretracheal tissue dissection. At this point, the endotracheal tube
FIGURE 1. Costal cartilages fashioned into tracheal rings. One end of
each rectangular cartilage piece was fashioned into the shape of a triangle.FIGURE 2. Preoperative (A) and postoperative (B) view of the cervical flap and the double-Z plasty. Cervical skin flap: A, incision made over the last pal-
pable rib for excision of the costal cartilage;B, cervical skin flap used for reconstruction;C, coverage of the tracheal reconstructionwith a double-Z skin plasty;
D, cervical drainage.Cardiovascular Surgery c Volume 138, Number 1 33
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flap reinforced with cartilage rings harvested from thoracic ribs rolled around a silicone stent; C, 6 cm of the trachea were then measured and removed with
cross-table ventilation; D, proximal and distal anastomoses between the trachea and the reconstruction flap.was withdrawn to the second tracheal ring. The trachea was measured and
then divided 4 cm above the carina. Cross-table ventilation was instituted to
ventilate at the level of the carina. Six centimeters of the trachea were mea-
sured and resected, starting slightly below the cricoid cartilage.
The flap was prepared by measuring positions 1 cm apart along the
length of the skin flap. A straight hemostat was used to dissect a plane be-
tween the dermal layers at half-centimeter intervals. The preprepared costal
cartilages were then inserted at each of these 0.5-cm intervals. Each costal
cartilage was secured to the skin–rib sandwich with 4–0 Prolene stitches
(Ethicon, Issy-les-Moulineaux, France).
A 6 cm 3 14 mm–diameter ribbed silicon stent was laid on the tissue
flap. This tissue flap was rolled around the silicone stent and secured with
a running 4–0 Prolene stitch. The external layer of the skin becomes the en-
doluminal layer of the neotrachea, like a mucosa. Thus dermal secretions
pour out into the tracheal lumen. The skin graft was sutured closed and
planted in the native tracheal position without any further mobilization of
the cervical skin flap. Indeed, as shown in Figures 3 and 4, the distance be-
tween the flap base and the tracheal bed was limited, allowing free tension
anatomoses. A rubber catheter was sutured to the endotracheal tube to facil-
itate its further replacement. This endotracheal tube was then withdrawn up-
ward through the vocal cords. The cross-table endotracheal tube was
removed from the distal trachea intermittently to facilitate placement of
the sutures. The neotrachea was reanastomosed in the following fashion.
First, the posterior membrane of the proximal and distal anastomoses was
secured with a continuous, running 4–0 Prolene suture. Then the cross-table
endotracheal tube was removed, and the original endotracheal tube was ad-
vanced to lie above the carina. Finally, full-thickness, 4–0 Prolene interrup-
ted sutures were performed on the anterior wall of the neotrachea and native
trachea at the proximal and distal anastomoses. As shown in Figures 3 and 4,
all the suture lines were covered by the endotracheal silicone stent to avoid
a postoperative airway collapse. The suture lines were tested with saline
over the sites. Defects were repaired (Figures 3 and 4).34 The Journal of Thoracic and Cardiovascular SurAfter division of its sternal insertions, the left sternohyoid muscle was
then flapped along the length of the longitudinal suture of the neotrachea
and secured with a running 4–0 Prolene stitch to separate this suture from
the skin suture. A 20F drain was placed along the length of the anastomoses.
The skin flap site was closed in a Z plasty closure (Figure 2). The length of
the buried skin between the base of the flap and the neotrachea is shortened
as much as possible to avoid inclusion of dermal cysts. Flexible bronchos-
copy was performed at the end of the procedure to examine the tracheal
lumen (Figure 5).
Postoperative Care
Postoperatively, the animals were extubated at the end of the procedure.
Animals were placed in cages and fed standard laboratory pig food and wa-
ter ad libitum. The cervical drain was removed at day 1. Animals were
treated daily with intramuscular cefotaxime (1 g) and gentamicin (80 mg).
Postoperative Monitoring and Assessment
The animals were monitored in an animal facility with approved safety
measures. The animals were inspected daily for wound healing and respira-
tory distress. The viability of the Z-plasty closure flap was examined daily.
Animal weight gain was measured once a week.
Fiberoptic flexible bronchoscopy. Once a week, the animals
were sedated and intubated. Fiberoptic bronchoscopy (Model BF1T240;
OlympusOptical CoLtd, Tokyo, Japan)was performed to examine the anas-
tomosis and viability of the graft. Fiberoptic examinations were performed
in each of the following sites on postoperative days 2, 7, 14, and 21: prox-
imal anastomosis, midprosthesis, distal anastomosis, carina, right main
bronchus, and left main bronchus (Figure 5). If animals had acute respiratory
insufficiency, stridor, or grunting, we immediately performed fiberoptic
bronchoscopy. The silicon stent was transparent, which permitted visualiza-
tion of the flap viability, as well as proximal or distal granulation tissue.gery c July 2009
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Fabre et al General Thoracic SurgeryFIGURE 4. Diagrams showing the steps of tracheal reconstruction: A, the autologous cervical skin flaps with the cartilage rings inserted between the dermal
layers; B, although 6 cm of the trachea were resected and a cross-table ventilation was instituted to ventilate at the level of the carina, the neotrachea is fash-
ioned by rotating the flap around a silicone stent; C, distal and proximal anastomoses were then performed around the stent and the animal ventilated through
a standard endotracheal tube advanced into the stent.Postmortem autopsy examinations. The animals were killed
(barbiturate overdose) at 1 week (group I, n ¼ 4 animals), 2 weeks (group
II, n¼ 4 animals), and 5 weeks (group III, n¼ 4). In group III the stent was
removed 1 week before death. All grafts were submitted to postmortem
macroscopic and histologic examinations. Any gross evidence of granula-
tion, obstructive lesions, or stent migration was noted during autopsy.The Journal of Thoracic andTissue biopsy and postmortem specimens were immediately fixed in
Bouin’s fixative and in 10% buffered formalin, respectively. After being
embedded in paraffin, 5-mm-thick sections of the trachea were stained
with hematoxylin and eosin. The specimens were examined for gross and
histologic abnormalities, including ischemia, inflammation, necrosis, and
thrombosis.FIGURE 5. Bronchoscopic view of the artificial conduit confirms well-healed tissue in the airway lumen at 1 month: A, proximal anastomosis; B, view of the
skin flap inside the silicone stent; C, distal anastomosis.Cardiovascular Surgery c Volume 138, Number 1 35
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criteria defined by other groups.11,12 The condition of the tracheal recon-
struction was assessed according to the following arbitrary semiquantita-
tive 0- to 5-point scale (Table 1): 1, good vascularization of the flap and
the cartilage ribs (in the absence of inflammation); 2, isolated lesions of
the epithelium; 3, partial ischemic necrosis of the flap (loss of nuclear
basophilic chondrocyte or epithelial cell); 4, complete acute necrosis;
and 5, primary or secondary infection of the flap (in the presence of poly-
nuclear cell infiltrate into the skin flap and cartilage ribs with leukocytic
debris, germs, or both).
RESULTS
Overall, this procedure was well tolerated by all the pigs.
There were no deaths during the study. Weight gain was ap-
propriate in all animals. On bronchoscopy, there was no ev-
idence of suture-line dehiscence, but a symptomatic distal
granuloma attached to the end of the stent was removed in
5 cases by using rigid bronchoscopy. In group III 3 animals
tolerated stent removal at 4 weeks. One animal required stent
reinsertion because of respiratory distress caused by trache-
omalacia.
In group I (Table 2) all the animals were extubated imme-
diately after tracheal replacement. The viability of the skin
flaps was confirmed at 1 week by means of bronchoscopy.
The proximal and distal anastomoses were clearly visual-
ized, confirming that there was no evidence of flap necrosis.
One animal did have progressive dyspnea. Bronchoscopy
demonstrated a granuloma attached to the distal edge of
the stent. On histologic examination, there was no evidence
of inflammation or ischemia in 3 of the 4 cases. Histologic
examination of the pig with tracheal granuloma showed
isolated lesions of the epithelium and partial necrosis of
the cartilage ribs; however, the skin flap remained viable.
TABLE 1. Semiquantitative histologic classification of the tracheal
lesions after reconstruction.
Histologic no. Histologic description
1 Good vascularization of the flap and of the
cartilage ribs (in the absence of inflammation)
2 Isolated lesions of the epithelium
3 Partial ischemic necrosis of the flap (loss of nuclear
basophilic chondrocyte or epithelial cell)
4 Complete acute necrosis
5 Primary or secondary infection of the flap (in the
presence of polynuclear cell infiltrate into
the skin flap and cartilage ribs with leukocytic
debris, germs, or both)36 The Journal of Thoracic and Cardiovascular SurIn group II (Table 3) all the animals tolerated extubation
immediately after surgical intervention. The skin flaps
were examined at 1 and 2 weeks and appeared viable. The
graft in the stented trachea and those in the proximal and dis-
tal anastomoses were clearly visualized. In this group 2 an-
imals had progressive dyspnea. Bronchoscopy demonstrated
distal granuloma. We performed a bronchoscopic resection
of the granuloma. After death, gross examination of the tra-
cheal substitute demonstrated excellent viability of the skin
flap with good epithelialization of the cartilaginous ribs into
the flap on histology.
In group III (Table 4) all animals were extubated immedi-
ately after tracheal surgery. Bronchoscopic examination of
the skin flaps at 1 week, 2 weeks, and 1 month demonstrated
excellent graft viability. In this group 2 animals had progres-
sive dyspnea. Bronchoscopy demonstrated distal granulo-
mas. We performed a bronchoscopic resection of the
granuloma. Three animals tolerated the stent removal at 4
weeks. One animal required stent reinsertion because of re-
spiratory distress caused by tracheomalacia. After death at 5
weeks, gross examination of the graft appeared to have good
flap viability with excellent incorporation of the cartilagi-
nous ribs with the skin graft in 3 of the 4 cases (Figure 6).
In the animal that had cartilage necrosis with tracheomala-
cia, gross examination showed a local infection along a car-
tilage ring, and histologic studies showed partial necrosis of
the chondrocytes, with good viability of the remaining flap
(Figure 7).
DISCUSSION
Tracheal surgery remains the mainstay of therapy for
several airway diseases. Management of both benign and
malignant tracheal diseases often requires long-segment re-
placement of portions of the trachea. Thoracic surgeons
remain challenged by the lack of appropriate substitute
TABLE 2. Group I: clinical, bronchoscopic, and histologic outcome at
1 week after tracheal reconstruction.
Animal no. Clinical evaluation
Bronchoscopic
evaluation at 1 wk Histology
563 Subcutaneous
emphysema
Small fistula 1
568 Good 1
794 Dyspnea Good with granuloma 2
974 Good 1TABLE 3. Group II: clinical, bronchoscopic, and histologic outcome at 2 weeks after tracheal reconstruction.
Animal no. Clinical evaluation Bronchoscopic evaluation at 1 wk Bronchoscopic evaluation at 2 wk Histology
924 Dyspnea Good with granuloma Good with granuloma 1
596 Dyspnea Good with granuloma Resection granuloma 1
955 Good Good 1
978 Good Good 1gery c July 2009
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anastomosis with limited resections and release maneuvers
to decrease tension. As Hermes Grillo noted, the current
technologies that are being used for tracheal replacement
have had a very poor success rate.13 However, the opportu-
nity for developing a novel tracheal substitute is now
possible with the rapid advancement in tracheal stents, im-
munosuppression, and our knowledge about skin flaps.
The ideal tracheal substitute should have 5 basic properties:
lateral rigidity, vertical elasticity, airtight lumen, continuous in-
ternal lining of the respiratory mucosa, and reliable healing.13
Artificial prostheses are prone to infection, granulation,
and obstruction with poor tissue incorporation. Furthermore,
because of the constant exposure of the trachea to the outside
environment, infections tend to develop around the anasto-
mosis, causing necrosis, large air leaks, and respiratory in-
sufficiency. These prostheses have been known to erode
and develop fistulas into surrounding structures, such as
the innominate artery and aorta.
Alternative biocompatible substitutes have also been
studied. Allogenic aortic segments have been used in animal
models. Neotracheas have been developed from aortic grafts
TABLE 4. Group III: clinical, bronchoscopic, and histologic outcome
at 5 weeks after tracheal reconstruction (1 week after stent removal).
Bronchoscopic evaluation
Animal
no.
Clinical
evaluation 1 wk 2 wk 5 wk Histology
564 Dyspnea Good Good with
granuloma
Granuloma 1
846 Good Good Good 1
58 Dyspnea Good Good with
granuloma
Granuloma 3
902 Good Good Good 1The Journal of Thoracic andthat have been molded for tracheal replacement. These neo-
tracheas have been modified with cartilage rings and demon-
strated on a sheep model with some promising results.14-16
The neotracheas have been able to somewhat incorporate
into the recipient trachea. Martinod and colleagues14-16 hy-
pothesized that environmental factors might have triggered
recipient cell differentiation. The explanation for this tra-
cheal regeneration is not understood. In contrast, Jaillard
and coworkers17 have not been able to reproduce these re-
sults. In their study epithelial growth was incomplete, and
only scattered islets of cartilage formed structurally impor-
tant tissue. In this series there was a high mortality rate.
The tracheal replacement with aortic fresh allograft has
been reported in 2 patients by Wurtz and associates after ex-
perimental replacement,17,18 but the bifurcated silicone stent
has not been removed for the 2 patients. Poor vascularization
and graft immunogenicity remain the main challenges after
these experimental allografts. Various procedures for restor-
ing circulation have been attempted, such as wrapping mus-
cle or omentum around the tracheal substitute.7,8,19 Some
investigators have attempted to use various vascular growth
factor to improve blood supply to the grafts.20 Pretreating
tracheal allografts has been used with limited success.9
Cryopreservation reduces acute rejection21; however, the al-
lograft ultimately succumbs to chronic rejection with vascu-
lar thrombosis and degeneration.22
Several groups have reported the potential use of tracheal
segment transplantation. In our institution we have de-
scribed a technique to transplant the entire trachea, carina,
and main stem bronchi.11 We have been able to preserve
the vascularization to the transplanted segment of the air-
way. In human subjects a short human tracheal segment
(pharyngolaryngotracheal segment) has been transplanted
with 40-month follow-up.23 However, this approach has
been limited by challenges with immunosuppression andFIGURE 6. Gross examination of the explanted neotrachea at 5 weeks.Cardiovascular Surgery c Volume 138, Number 1 37
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gradable matrices with autologous stem cells have been
introduced.24-27 However, there has been no ultimate tis-
sue-engineered tracheal prosthesis that has been readily
available and technically simple to use.19
In 1959, Serrano and colleagues28 inserted a series of bi-
lateral hemirings of cartilage carved from the costal arch to
provide support to skin that was finally closed anteriorly. In
1964, Grillo and associates29 developed a staged repair of
the cervical trachea to replace a cervical tracheal segment.
A cutaneous tube was formed in stages and supported by
polypropylene rings inserted between the dermis and the at-
tached platysma muscle. The cervical trachea was recon-
structed experimentally by forming a cutaneous trough
supported by cartilage or plastic rings. Staged closure of
the trough was performed on dogs.30
A tracheal reconstruction with a tubed radial forearm graft
around a stent has been described by Beldholm and
coworkers.4 The stent provided stability and a patent airway.
To our knowledge, only 1 patient has ever been treated
successfully with a long-segment replacement (6.5 cm) of
his trachea with a composite radial forearm free flap and
prosthesis.10 In this case a 63-year-old woman was treated
with a conduit composed of a radial forearm free flap lined
with a composite PolyMax mesh (Synthes, Paoli, Pa) and
Hemashield vascular graft (Boston Scientific, Natick,
Mass) for rigid support. At 6 months’ follow-up, the patient
had normal swallowing and preoperative voice quality and
a patent nonstented airway. This approach of using a vascu-
larized autogenous tissue flap as a tube after circumferential
resection seems to be the most promising approach.
This article presents a novel approach to developing a neo-
trachea by using autologous tissues with an independent
blood supply in a 1-stage surgical procedure. The 5 basic
properties desired for an ideal long tracheal substitute were
FIGURE 7. Histologic examination of the artificial conduit at 5 weeks
demonstrates good viability.38 The Journal of Thoracic and Cardiovascular Surachieved. For lateral rigidity, we used cartilage ribs. For ver-
tical elasticity, we used a cervical skin flap. To maintain the
airtight lumen, we used an endoluminal stent that could be
removed at a later date. We chose a pedicled flap because
it is more reliable than a free flap and avoided the need for
a microvascular anastomosis. The flap provided sufficient
blood supply for neovascularization of the cartilaginous
rib fragments. The size of the cervical flap depends on the
length of the trachea to replace. The width of the cervical
skin flap should not exceed 150% of the length of the
flap. Animals that had wider flaps had airway obstruction
(data not shown).
This surgical procedure can be readily reproduced. We
have been able to consistently replace more than 50% of
the trachea with good long-term outcomes. This experimen-
tal model is relatively easy to perform. The tissues remain
viable at 1, 2, and 4 weeks. Gross examination of the tracheal
reconstruction demonstrates viability of the skin flap with
good incorporation of the engineered composite graft of
the cartilage rib fragments into the flap (Figure 6).
There are limitations to this neotrachea model. First, there
remains the risk of stent obstruction caused by mucus plug-
ging during the first several days after the procedure. Fiber-
optic bronchoscopy must be used judiciously to maintain the
patency of the airway during this period. The pressure ex-
erted by the endoluminal stent can lead to tissue inflamma-
tion, ischemia, and granulation. Granulation tissue has the
potential to cause luminal stenosis or obstruction. Another
limitation to this cervical flap is the difficulty for reproduc-
tion in human subjects. Indeed, the cervical skin flap is prob-
ably not suitable in clinical practice because the cervical skin
in human subjects is less extensive than that in pigs, in which
the neck area is larger and shorter. We plan to use a free skin
flap with its own arterial and venous vascularization. The
blood supply to this free flap will be carried by performing
arterial and venous microvascular anastomoses with a cervi-
cal vascular pedicle. In human subjects it can be a free fore-
arm skin flap pedicled on the radial artery and vein. These
vessels could then be anastomosed to the internal thoracic
artery and vein.
In conclusion, we present the first described animal model
for tracheal resection and replacement with an autologous
conduit constructed from costal cartilages and cervical
skin flaps. This model is relatively simple and reproducible.
The experimental model has excellent short-term good via-
bility. Further studies evaluating long-term results are still
warranted. Follow-up of 5 or 6 months after stent removal
is necessary to definitely declare the technique a success.
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